For more detailed information contact your manager
We serve the needs of our people
0% Transaction
Fee
Spreads starts
from 0.1 pips
20% to 100% bonus
offers
NO.1 Webtrader
Terminal
Ultra fast
execution (3MS)
Leverage up to
1:100Beginner €250 Leverage 1:20 Standards spreads from 0.8
pips Trading instruments: currency pairs . Low commissions . .
Standard €2 000 Leverage 1:100 Standards spreads from 0.6
pips Trading instruments: currency pairs, commodity
exchange . Low
commissions . .
Gold €10 000 Leverage 1:100 Standards spreads from 0.5
pips Trading instruments: currency pairs, commodity exchange,
stock market, cryptocurrency . Low commissions . .
Corporate €150 000
Leverage 1:100 Standards spreads from 0.4
pips Trading instruments: currency pairs, commodity exchange,
stock market, indices, cryptocurrency . Individual offer . .
VIP Individual
conditions Leverage 1:100 Standards
spreads - floating Special offers from partner banks Individual offer
Instruments & Promotions
Currency Currency pairs are popular with millions of traders as well as investment
funds and banks for a reason. It is a liquid, predictable and highly profitable asset
that allows traders of any level to earn money.
Metals Precious and semi-precious metals have been traded for thousands of years.
Despite their age, they are still a versatile and effective trading instrument.
Stocks Securities of large companies are one of the most reliable and, at the same
time, highly profitable assets. Buying shares you can receive passive income in the form
of dividends or active income from trading.
Cryptocurrency
Cryptocurrencies are the youngest and most profitable type of assets.
They bring enormous income to experienced traders, thanks to active trading, and allow
beginners to make a fortune by investing in promising startups.
Prize draw By Special
Partners.
20% Deposit Bonus Support
floating & margin.
Receive a special deposit bonus Flexible loyalty programme.
Join forces with us as partners
We provide a range of partnership options tailored to meet your individual or
group preferences, allowing you to capitalize on the growth of your network.
Partners Benefits
Enjoy various types of advantages by becoming our world-class introducer.
Level up your
network
In the world of cryptocurrencies,
our partners have unique opportunities for growth and development.
Unlimited Income
Lot Contribution
Program
Multi-Tier
Overriding
Sales Acquisition Revenue
Multi-Tier OverridingStart trading with Capital Systematics in just a few simple steps
Activate your trading account Open an account with Capital Systematics.
Verify Go through the
verification procedure with the help of a manager, or simply upload documents
via your personal account.
Start trading Fund your
account with Capital Systematics and start trading on our advanced
platform.
News
1 January 2025
Encourages Xerox Holdings Corporation Investors to Secure Counsel Before Important January 21 Deadline in Securities Class Action - XRX
New York, New York -- (Newsfile Corp. - January 18, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Xerox (NASDAQ:XRX) Holdings Corporation (NASDAQ: XRX) between January 25, 2024 and October 28, 2024, both dates inclusive (the "Class Period"), of the important January 21, 2025 lead plaintiff deadline.
SO WHAT: If you purchased Xerox securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
12 January 2025
APPLIED THERAPEUTICS, INC. (APLT) Investors are Notified the Company has been Sued for Securities Fraud and are Urged to Contact BFA Law by February 18
New York, New York--(Newsfile Corp. - January 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: NASDAQ:APLT) and certain of the Company's senior executives for potential violations of the federal securities laws.
If you invested in Applied Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/applied-therapeutics-inc.
Investors have until February 18, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Applied Therapeutics securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Alexandru v. Applied Therapeutics, Inc., et al., No. 24-cv-09715.
3 January 2025
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DENTSPLY SIRONA
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Dentsply To Contact Him Directly To Discuss Their Options
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Dentsply targeted low-income people who did not have access to good oral hygiene education, a dentist, or dental insurance, which often meant patients signing up for Byte had underlying dental issues that would have made them
7 January 2025
MARQETA, INC. (MQ) Investors are Notified the Company has been Sued for Securities Fraud and are Urged to Contact BFA Law
New York, New York--(Newsfile Corp. - January 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Marqeta , Inc. (NASDAQ: NASDAQ:MQ) and certain of the Company's senior executives for potential violations of the federal securities laws.
If you invested in Marqeta, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/marqeta-inc...